Deal Library / Pharma BD Deal Intelligence

Mitsubishi Tanabe Pharma Corporation — Pharma Deals

The Pharma Closeout tracks 4 deals, $1.1B in disclosed deal value, 1 with a post-close Outcome Score for Mitsubishi Tanabe Pharma Corporation.

Median Critic Score: 50  ·  Median Outcome Score: 36

All 4 deals

• Mitsubishi Tanabe Pharma Corporation / NeuroDerm Ltd. — 2017 · $1.1B · Underwhelmed — fell short of the thesis.
• Mitsubishi Tanabe Pharma Corporation / GV20 Therapeutics — 2025
• Mitsubishi Tanabe Pharma Corporation / EditForce, Inc. — 2022
• Mitsubishi Tanabe Pharma Corporation / Viela Bio Inc. — 2019

← Deal Library  ·  Interactive search  ·  How we score deals